Back
Edwards Lifesciences Corp (EW)
Health CareEW · NEW YORK STOCK EXCHANGE, INC. · USD
New to investing? How to read this page →$87.23
+2.44%Weekly undervalued picks
Price · 1 year
Loading live analysis…
Loading analysis…
Intrinsic Investor is for research and education only. Not financial advice.
Key metrics
EPS
$1.83
ROE
10.5%
Gross margin
77.9%
Debt/Equity
6.81x
Revenue growth
16.7%
Edwards Lifesciences Corp — company intelligence
Earnings surprises
Q2 2026$0.78 vs $0.76 est+2.3%
Q1 2026$0.78 vs $0.75 est+4.2%
Q4 2025$0.58 vs $0.64 est-8.8%
Q3 2025$0.67 vs $0.61 est+9.6%
Analyst consensus · 40 analysts
31 Buy9 Hold0 Sell
Updated Oct 5, 2026
Insider activity · 90 days
0 buys11 sellsnet -40,869 shares
Markowitz WayneSell 568 · Sep 14, 2026
Dahl Andrew M.Sell 253 · Sep 13, 2026
Markowitz WayneSell 355 · Sep 11, 2026
Recent SEC filings
4 — Insider transaction reportSep 14, 2026
4 — Insider transaction reportSep 14, 2026
4 — Insider transaction reportSep 11, 2026
Latest news
How Investors May Respond To Edwards Lifesciences (EW) Expanded TAVR Access And Transcatheter Valve Ambitions — Yahoo · 3w ago
Interventional Cardiology Devices Market by Type, End User - Global Forecast to 2031 — Yahoo · 3w ago
Edwards Lifesciences Sees TAVR Expansion, $2B TMTT Opportunity Ahead — Yahoo · 3w ago
What's going on in today's session: S&P500 movers — ChartMill · 3w ago
AI Valuation Narrative
Generates a short bull / bear / catalyst summary from the analytics we already computed. No target prices. Research tool, not investment advice.
Explore more
Peers & similar stocks
Quick links to related tickers for research.
Weekly undervalued picks
Get 3 new value ideas and the fair-value math behind them every week. One email, unsubscribe anytime.
Free. No spam. We only email once per week.
Data is provided "as-is" and may be delayed or incomplete. Intrinsic Investor is for education only and is not investment advice.